ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Donor-Derived Cell-Free DNA Combined with Histology Improves Prediction of eGFR Decline in Kidney Transplant Recipients over Histology Alone

M. Gillespie, M. Haas, K. Lim, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan, E. Huang

Cedars-Sinai, Los Angeles, CA

Meeting: 2020 American Transplant Congress

Abstract number: A-295

Keywords: Biopsy, Kidney transplantation, Prediction models, Renal function

Session Information

Session Name: Poster Session A: Biomarkers, Immune Assessment and Clinical Outcomes

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Higher Banff inflammation and chronicity scores on kidney transplant (KTx) biopsies (Bx) have been associated with poorer graft survival, but Bx scores alone imperfectly predict outcomes. Incorporating rejection biomarkers may improve prognostic assessment but has yet to be studied. We investigated if integrating donor-derived cell-free DNA (dd-cfDNA, Allosure©; CareDx, Inc.; Brisbane, CA) with Banff Bx scores into a predictive model for eGFR decline can improve model fit vs. Bx scores alone.

*Methods: We identified 185 pts >/= 1 month post-KTx who had dd-cfDNA assessed within one month of Bx (median 13 days, IQR: 6-19 days). We used linear mixed effects models to derive a prediction model of Banff inflammation and chronicity scores and dd-cfDNA on eGFR (CKD-EPI) over time. Nested models were compared using the likelihood ratio test, AIC, and BIC to assess if inclusion of dd-cfDNA into a parsimonious model consisting of Banff Bx scores would improve model fit.

*Results: Bxs were performed a median of 693 days post-KTx (IQR: 99-2132 days). Overall, 25 pts had isolated cell-mediated rejection (CMR), 58 had isolated antibody-mediated rejection (ABMR), 13 had mixed CMR/ABMR, and 89 had no rejection. Univariate models identified significant group x time interactions for cg=3 vs. cg<3 and ci+ct >/= 3 vs. ci+ct<3; statistical interaction with time was non-significant for i, t, v, i-IFTA scores, and log-transformed dd-cfDNA (ln dd-cfDNA) (Table 1). Addition of acute inflammation (i, t, and v-scores) and i-IFTA scores to chronicity scores (cg=3 and ci+ct >/= 3) did not improve model fit. However, a model including ln dd-cfDNA with cg and ci+ct had a better model fit compared to cg and ci+ct alone (Table 2).

*Conclusions: Inclusion of dd-cfDNA, but not inflammation scores, with chronicity scores into a predictive model improved prediction of eGFR decline vs. chronicity scores alone. While there was only a trend toward a significant association of dd-cfDNA and eGFR trajectory, the direction of the dd-cfDNA x time interaction suggests higher dd-cfDNA may be associated with eGFR decline and should be validated in larger datasets.

 border=

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gillespie M, Haas M, Lim K, Vo A, Peng A, Najjar R, Sethi S, Jordan S, Huang E. Donor-Derived Cell-Free DNA Combined with Histology Improves Prediction of eGFR Decline in Kidney Transplant Recipients over Histology Alone [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/donor-derived-cell-free-dna-combined-with-histology-improves-prediction-of-egfr-decline-in-kidney-transplant-recipients-over-histology-alone/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences